Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review

Reference

• ABDEL-RAZZAK, Z., LOYER, P., FAUTREL, A., GAUTIER, J. C., CORCOS, L., TURLIN, B., BEAUNE, P. and GuILLouzo, A., 1993, Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Molecular Pharmacology, 44,707–715.
   Google Scholar
• AHMED, J. H., GRANT, A. C., RODGER, R. S., MURRAY, G. R. and ELLIOTT, H. L., 1991, Inhibitory effect of uraemia on the hepatic clearance and metabolism of nicardipine. British Journal of Clinical Pharmacology, 32, 57–62.
   PubMed Web of Science ®Google Scholar
• AIELLO, S., NORIS, M. and REMUZZI, G., 1997, Nitric oxide synthesis and L-arginine in uremia. Mineral and Electrolyte Metabolism, 23, 151–156.
   PubMedGoogle Scholar
• AIELLO, S., NORIS, M. and REMUZZI, G., 1999, Nitric oxide/L-arginine in uremia. Mineral and Electrolyte Metabolism, 25, 384–390.
   PubMedGoogle Scholar
• AKAHOSHI, T., KOBAYASHI, N., HOSAKA, S., SEKIYAMA, N., WADA, C. and KONDO, H., 1995, In-vivo induction of monocyte chemotactic and activating factor in patients with chronic renal failure. Nephrology, Dialysis, Transplantation, 10, 2244–2249.
   PubMed Web of Science ®Google Scholar
• ALEXANDER, B., 1998, The role of nitric oxide in hepatic metabolism. Nutrition, 14, 376–390.
   PubMed Web of Science ®Google Scholar
• ALI, M., NicHoLLs, P. J. and YOOSUF, A., 1979, The influence of old age and of renal failure on hepatic glucuronidation in the rat. British Journal of Pharmacology, 66, 498P–499P.
   Google Scholar
• ANDERS, M. W., 1980, Metabolism of drugs by the kidney. Kidney International, 18, 636-647. AOYAGI, K., NAGASE, S., GOTOH, M., AKIYAMA, K., SATOH, M., HIRAYAMA, A. and KOYAMA, A., 1996, Role of reactive oxygen and argininosuccinate in guanidinosuccinate synthesis in isolated rat hepatocytes. Enzyme and Protein, 49, 205–211.
   Google Scholar
• AOYAGI, K., SHAHRZAD, S., IIDA, S., TOMIDA, C., HIRAYAMA, A., NAGASE, S., TAKEMURA, K., KOYAMA, A., OHBA, S., NARITA, M. and COHEN, B. D., 2001, Role of nitric oxide in the synthesis of guanidinosuccinic acid, an activator of the N-methyl-D-aspartate receptor. Kidney International Supplement, 78, S93—S96.
   Google Scholar
• BAER, P. C., NOCKHER, W. A., HAASE, W. and SCHERBERICH, J. E., 1997, Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Kidney International, 52, 1321–1331.
   PubMedGoogle Scholar
• BALABANOV, S., ZIMMERMANN, U., PROTZEL, C., SCHARF, C., KLEBINGAT, K. J. and WALTHE R., 2001, Tumor-related enzyme alterations in the clear cell type of human renal cell carcinoma identified by two-dimensional gel electrophoresis. European Journal of Biochemistry, 268, 5977–5980.
   PubMedGoogle Scholar
• BALANT, L., FRANCIS, R. J., TOZER, T. N., MARMY, A., TSCHOPP, J. M. and FABRE, J., 1980, Influence of renal failure on the hepatic clearance of bufuralol in man. Journal of Pharmacokinetics and Biopharnzaceutics, 8, 421–438.
   PubMedGoogle Scholar
• BARAKAT, M. M., EL-KADI, A. 0. and DU SOUICH, P., 1997, In vivo, ex vivo, and in vitro effects of L-NAME and L-arginine on the metabolism of theophylline in the rabbit. Drug Metabolism and Disposition, 25, 191–195.
   Google Scholar
• BARAKAT, M. M., EL-KADI, A. 0. and DU SOUICH, P., 2001, L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction. Life Sciences, 69, 1559–1571.
   Google Scholar
• BARTH, H., NABER, K., BARTHEL, K. E., NIEMEYER, I. and LORENZ, W., 1975, Induction of histamine methyltransferase during experimental hydronephrosis: a mechanism of adaptation for histamine homeostasis in rabbit kidney. Agents and Actions, 5, 442–443.
   PubMedGoogle Scholar
• BERTILSSON, P. M., OLSSON, P. and MAGNUSSON, K. E., 2001, Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells. Journal of Pharmaceutical Sciences, 90, 638–646.
   PubMed Web of Science ®Google Scholar
• BLEAU, A. M., FRADETTE, C., EL-KADI. A. 0., COTE, M. C. and DU SOUICH, P., 2001, Cytochrome P450 down-regulation by serum from humans with a viral infection and from rabbits with an inflammatory reaction. Drug Metabolism and Disposition, 29, 1007–1012.
   Google Scholar
• CAPPIELLO, M., FRANCHI, M., GIULIANI, L. and PACIFICI, G. M., 1989, Distribution of 2-naphthol sulphotransferase and its endogenous substrate adenosine 3'-phosphate 5'-phosphosulphate in human tissues. European Journal of Clinical Pharmacology, 37, 317–320.
   PubMedGoogle Scholar
• CAPPIELLO, M., GIULIANI, L. and PACIFICI, G. M., 1991, Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5'-diphosphoglucuronic acid in human tissues. European Journal of Clinical Pharmacology, 41, 345–350.
   PubMed Web of Science ®Google Scholar
• CARROLL, M. A., ESCALANTE, B. and McGIFF, J. C., 1990, Cytochrome P-450 metabolites of arachidonic acid: implications for blood pressure regulation. Polish Journal of Pharmacology and Pharmacy, 42, 191–201.
   PubMedGoogle Scholar
• CHAPMAN, A. E. and GOLDSTEIN, L. J., 1995, Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma. Seminars in Oncology, 22, 17–28.
   PubMedGoogle Scholar
• CHEUNG, Y. L., KERR, A. C., MCFADYEN, M. C., MELVIN, W. T. and MURRAY, G. I., 1999, Differential expression of CYP1A1, CYP1A2, CYP1B1 in human kidney tumors. Cancer Letters, 139, 199–205.
   PubMedGoogle Scholar
• Clio, M. K., KIM, Y. G., LEE, M. G. and Km, S. G., 1999, Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: complete or partial restoration by cysteine or methionine supplementation. Archives of Biochemistry and Biophysics, 372, 150–158.
   PubMedGoogle Scholar
• CHUNG, H. C., KIM, S. H., LEE, M. G. and KIM, S. G., 2002, Increase in urea in conjunction with L-arginine metabolism in the liver leads to induction of cytochrome P450 2E1 (CYP2E1): the role of urea in CYP2E1 induction by acute renal failure. Drug Metabolism and Disposition, 30,739–746.
   PubMed Web of Science ®Google Scholar
• CLYNE, C. D., WHITE, P. C. and RAINEY, W. E., 1996, Calcium regulates human CYP11B2 transcription. Endocrinology Research, 22, 485–492.
   PubMed Web of Science ®Google Scholar
• COJOCEL, C., MATTA, K., PASINO, D. A., Kuo, C. H. and HOOK, J. B., 1983, Metabolic heterogeneity of the proximal and distal kidney tubules. Life Sciences, 33, 855–861.
   PubMedGoogle Scholar
• COOPER, A. L., BROUWER, S., TURNBULL, A. V., LUHESHI, G. N., HOPKINS, S. J., KUNKEL, S. L. and ROTHWELL, N. J., 1994, Tumor necrosis factor-alpha and fever after peripheral inflammation in the rat. American Journal of Physiology, 267, R1431—R1436.
   Google Scholar
• COWLEY, B. D., JR, MUESSEL, M. J., DOUGLASS, D. and WILKINS, W., 1995, In vivo and in vitro osmotic regulation of HSP-70 and prostaglandin synthase gene expression in kidney cells. American Journal of Physiology, 269, F854–862.
   Google Scholar
• CUMMINGS, B. S., ZANGAR, R. C., NOVAK, R. F. and LASH, L. H., 1999, Cellular distribution of cytochromes P-450 in the rat kidney. Drug Metabolism and Disposition, 27, 542–548.
   PubMedGoogle Scholar
• CUTRIN, J. C., ZINGARO, B., CAMANDOLA, S., BOVERIS, A., POMPELLA, A. and POLI, G., 2000, Contribution of gamma glutamyl transpeptidase to oxidative damage of ischemic rat kidney. Kidney International, 57, 526–533.
   PubMed Web of Science ®Google Scholar
• DAVIS, B. B., MATTAMMAL, M. B. and ZENSER, T. V., 1981, Renal metabolism of drugs and xenobiotics. Nephron, 27, 187–196.
   PubMed Web of Science ®Google Scholar
• DAWLING, S., LYNN, K., ROSSER, R. and BRAITHWAITE, R., 1982, Nortriptyline metabolism in chronic renal failure: metabolite elimination. Clinical Pharmacology and Therapeutics, 32, 322–329.
   PubMed Web of Science ®Google Scholar
• DE CEAURRIZ, J. and BAN, M., 1990, Role of gamma-glutamyltranspeptidase and beta-lyase in the nephrotoxicity of hexachloro-1,3-butadiene and methyl mercury in mice. Toxicology Letters, 50, 249–256.
   PubMedGoogle Scholar
• DELBANCO, E. H., BOLT, H. M., HUBER, W. W., BEKEN, S., GELLER, F., PHILIPPOU, S., BRANDS, F. H., BRUNING, T. and THEI R., 2001, Glutathione transferase activities in renal carcinomas and adjacent normal renal tissues: factors influencing renal carcinogenesis induced by xenobiotics. Archives of Toxicology, 74, 688–694.
   PubMedGoogle Scholar
• DERBEL, M., IGARASHI, T. and SATOH, T., 1993, Differential induction of glutathione S-transferase subunits by phenobarbital, 3-methylcholanthrene and ethoxyquin in rat liver and kidney. Biochimca et Biophysica Acta, 1158, 175–180.
   PubMedGoogle Scholar
• DINGEMANSE, J. and VAN GIERSBERGEN, P. L., 2002, Influence of severe renal dysfunction on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist. International Journal of Clinical Pharmacology and Therapeutics, 40, 310–316.
   PubMed Web of Science ®Google Scholar
• DIPPLE, K. M. and CRABB, D. W., 1993, The mitochondrial aldehyde dehydrogenase gene resides in an HTF island but is expressed in a tissue-specific manner. Biochemical and Biophysical Research Communications, 193, 420–427.
   PubMedGoogle Scholar
• DOLPHIN, C, SHEPHARD, E. A., POVEY, S., PALMER, C. N., ZIEGLER, D. M., AYESH, R., SMITH, R. L. and PHILLIPS, I. R., 1991, Cloning, primary sequence, and chromosomal mapping of a human flavin-containing monooxygenase (FM01). Journal of Biological Chemistry, 266, 12379–12385.
   PubMed Web of Science ®Google Scholar
• DONATO, M. T., GUILLEN, M. I., JovEa, R., CASTELL, J. V. and GOMEZ-LECHON, M. J., 1997, Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes. Journal of Pharmacology and Experimental Therapeutics, 281, 484–490.
   Google Scholar
• EICKELMANN, P., EBERT, T., WARSKULAT, U., SCHULZ, W. A. and SIES, H., 1994, Expression of NAD(P)H:quinone oxidoreductase and glutathione S-transferases alpha and pi in human renal cell carcinoma and in kidney cancer-derived cell lines. Carcinogenesis, 15, 219–225.
   PubMed Web of Science ®Google Scholar
• EISEMAN, J. L., RIBAS, J. L., KNIGHT, E. and ALVARES, A. P., 1987, Acute nephropathy induced by gold sodium thiomalate: alterations in renal haem metabolism and morphology. Toxicology and Applied Pharmacology, 91, 193–203.
   PubMed Web of Science ®Google Scholar
• ELFARRA, A. A. and ANDERS, M. W., 1984, Renal processing of glutathione conjugates. Role in nephrotoxicity. Biochemical Pharmacology, 33, 3729–3732.
   PubMed Web of Science ®Google Scholar
• EL-KADI, A. 0. and Du Soumi, P., 1998, Depression of the hepatic cytochrome P450 by an acute inflammatory reaction: characterization of the nature of mediators in human and rabbit serum, and in the liver. Life Sciences, 63, 1361–1370.
   Google Scholar
• EL-KADI, A. 0., BLEAU, A. M., DUMONT, I., MAURICE, H. and DU SOUICH, P., 2000, Role of reactive oxygen intermediates in the decrease of hepatic cytochrome P450 activity by serum of humans and rabbits with an acute inflammatory reaction. Drug Metabolism and Disposition, 28, 1112–1120.
   Google Scholar
• EL-KADI, A. 0., MAURICE, H., ONG, H. and DU SOUICH, P., 1997, Down-regulation of the hepatic cytochrome P450 by an acute inflammatory reaction: implication of mediators in human and animal serum and in the liver. British Journal of Pharmacology, 121, 1164–1170.
   Google Scholar
• ELSTON, A. C., BAYLISS, M. K. and PARK, G. R., 1993, Effect of renal failure on drug-metabolism by the liver. British Journal of Anaesthesiology, 71, 282–290.
   PubMed Web of Science ®Google Scholar
• FAYED, H. M., KAME, M. A., SULTAN, M. M., MOWAFY, M. N., HELMY, S. M. and EL-ZOGHBY, M. H., 2002, Nitric oxide generation by peripheral blood cells in chronic renal failure. British Journal of Biomedical Sciences, 59, 24–29.
   Google Scholar
• FERNANDES, M. H. and SOARES-DA-SILVA, P., 1992, Type A and B monoamine oxidase activities in the human and rat kidney. Acta Physiologica Scandinavica, 145, 363–367.
   Google Scholar
• FILLASTRE, J. P., TABURET, A. M., FIALAIRE, A., ETIENNE, I., BIDAULT, R. and SINGLAS, E., 1993, Pharmacokinetics of lamotrigine in patients with renal impairment: influence of haemodialysis. Drugs Under Experimental and Clinical Research, 19, 25–32.
   PubMedGoogle Scholar
• FOSTER, J. R., ELCOMBE, C. R., BOOBIS, A. R., DAVIES, D. S., SESARDIC, D., MCQUADE, J., ROBSON, R. T., HAYWARD, C. and LOCK, E. A., 1986, Immunocytochemical localization of cytochrome P-450 in hepatic and extra-hepatic tissues of the rat with a monoclonal antibody against cytochrome P-450 c. Biochemical Pharmacology, 35, 4543–4554.
   PubMed Web of Science ®Google Scholar
• FROMM, M. F., BOTSCH, S., HEINKELE, G., EVERS, J. and KROEMER, H. K., 1995, Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its phase I and phase II metabolites. European Journal Clinical Pharmacology, 48, 279–283.
   PubMedGoogle Scholar
• GARGALIDIS-MOUDANOS, C., REMAURY, A., PIZZINAT, N. and PARINI, A., 1997, Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: regulation by 12 imidazoline ligands in intact cells. Molecular Pharmacology, 51, 637–643.
   PubMed Web of Science ®Google Scholar
• GIBSON, T. P., 1986, Renal disease and drug-metabolism: an overview. American Journal of Kidney Diseases, 8, 7–17.
   PubMed Web of Science ®Google Scholar
• GIBSON, T. P., ATKINSON, A. J., JR, MATUSIK, E., NELSON, L. D. and BRIGGS, W. A., 1977, Kinetics of procainamide and N-acetylprocainamide in renal failure. Kidney International, 12, 422–429.
   Google Scholar
• GOODMAN, A. I., CHOUDHURY, M., DA SILVA, J. L., SCHWARTZMAN, M. L. and ABRAHAM, N. G., 1997, Overexpression of the haem oxygenase gene in renal cell carcinoma. Proceedings of the Society for Experimental Biology and Medicine, 214, 54–61.
   PubMed Web of Science ®Google Scholar
• GREENSPAN, P. and BARON, J., 1980, Effect of unilateral nephrectomy on in vitro hepatic microsomal oxidative drug-metabolism in the rat. Proceedings of the Society for Experimental Biology and Medicine, 164, 307–311.
   PubMedGoogle Scholar
• GUAY, D. R., AWNI, W. M., FINDLAY, J. W., HALSTENSON, C. E., ABRAHAM, P. A., OPSAHL, J. A., JONES, E. C. and MATZKE, G. R., 1988, Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease. Clinical Pharmacology and Therapeutics, 43, 63–71.
   PubMed Web of Science ®Google Scholar
• GUEVIN, C., MICHAUD, J., NAUD, J., LEBLOND, F. A. and PICHETTE, V., 2002, Down-regulation of hepatic cytochrome P450 in chronic renal failure: role of uremic mediators. British Journal of Pharmacology, 137, 1039–1046.
   PubMed Web of Science ®Google Scholar
• GUIDET, B. and SHAH, S. V., 1989, Enhanced in vivo H202 generation by rat kidney in glycerol-induced renal failure. American Journal of Physiology, 257, F440—F445.
   Google Scholar
• HAKKOLA, J., PASANEN, M., PURKUNEN, R., SAARIKOSKI, S., PELKONEN, 0., MAENPAA, J., RANE, A. and RAUNIO, H., 1994, Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochemical Pharmacology, 48, 59–64.
   Google Scholar
• HANIGAN, M. H., GALLAGHER, B. C., TOWNSEND, D. M. and GABARRA, V., 1999, y-Glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis, 20, 553–559.
   PubMed Web of Science ®Google Scholar
• HJELLE, J. T., PETERSEN, D. R. and HJELLE, J. J., 1983, Drug-metabolism in isolated proximal tubule cells: aldehyde dehydrogenase, Journal of Pharmacology and Experimental Therapeutics, 224, 699–706.
   PubMed Web of Science ®Google Scholar
• HOLMES, R. S., COURTNEY, Y. R. and VANDEBERG, J. L., 1986, Alcohol dehydrogenase isozymes in baboons: tissue distribution, catalytic properties, and variant phenotypes in liver, kidney, stomach, and testis. Alcohol Clinical and Experimental Research, 10, 623–630.
   PubMedGoogle Scholar
• HOLMES, R. S., VAN OORSCHOT, R. A. and VANDEBERG, J. L., 1991, Aldehyde dehydrogenase (ALDH) isozymes in the gray short-tailed opossum (Monodelphis domestica): tissue and subcellular distribution and biochemical genetics of ALDH3. Biochemical Genetics, 29, 163–175.
   PubMedGoogle Scholar
• HORIKAWA, 5, ITO, K., IKEDA, S., SHIBATA, T., IsHizuKA, S., YANO, T., HAGIWARA, K., OZASA, H. and KATSUYAMA, I., 1998, Induction of haem oxygenase-1 in toxic renal injury: mercuric chloride-induced acute renal failure in rat. Toxicology Letters, 94, 57–64.
   Google Scholar
• IBER, H., LI-MASTERS, T., CHEN, Q., Yu, S. and MORGAN, E. T., 2001, Regulation of hepatic cytochrome P450 2C11 via cAMP: implications for down-regulation in diabetes, fasting, and inflammation. Journal of Pharmacology and Experimental Therapeutics, 297, 174–180.
   PubMed Web of Science ®Google Scholar
• IKEMOTO, S., IMAOKA, S., HAYAHARA, N., MAEKAWA, M. and FUNAE, Y., 1992, Expression of hepatic microsomal cytochrome P450s as altered by uremia, Biochemical Pharmacology, 43, 2407–2412.
   Google Scholar
• ImA0KA, S. and FUNAE, Y., 1991, Hepatic and renal cytochrome P-450s in spontaneously hypertensive rats. Biochimica et Biophysica Acta, 1074, 209–213.
   Google Scholar
• ITO, 0., ALONSO-GALICIA, M., Hopp, K. A. and MAN, R. J., 1998, Localization of cytochrome P-450 4A isoforms along the rat nephron. American Journal of Physiology, 274, F395–F404.
   Google Scholar
• KAPITULNIK, J. and STROBEL, H. W., 1999, Extrahepatic drug metabolizing enzymes. Journal of Biochemical and Molecular Toxicology, 13, 227–230.
   PubMed Web of Science ®Google Scholar
• KARUZINA, I. I., ARCHAKOV, A. I., KARUZINA, I. L. and ARCHAKOV, A. I., 1994, Hydrogen peroxide-mediated inactivation of microsomal cytochrome P450 during monooxygenase reactions. Free Radicals in Biology and Medicine, 17, 557–567.
   PubMed Web of Science ®Google Scholar
• KEVORKIAN, J. P., MICHEL, C., HOFMANN, U., JACQZ-AIGRAIN, E., KROEMER, H. K., PERALDI, M. N., EICHELBAUM, M., JAILLON, P. and FUNCK-BRENTANO, C., 1996, Assessment of individual CYP2D6 activity in extensive metabolisers with renal failure: comparison of sparteine and dextromethorphan. Clinical Pharmacology and Therapeutics, 59, 583–592.
   Google Scholar
• KIM, H. S., CHA, S. H., ABRAHAM, D. G., COOPER, A. J. and ENDOU, H., 1997, Intranephron distribution of cysteine S-conjugate beta-lyase activity and its implication for hexachloro-1,3-butadiene-induced nephrotoxicity in rats. Archives of Toxicology, 71, 131–141.
   PubMed Web of Science ®Google Scholar
• KIM, Y. G., SHIN, J. G., SHIN, S. G., JANG, I. J., KIM, S., LEE, J. S., HAN. J. S. and CHA, Y. N., 1993, Decreased acetylation of isoniazid in chronic renal failure. Clinical Pharmacology and Therapeutics, 54, 612–620.
   Google Scholar
• KIMMEL, P. L., LEW, S. Q., UMANA, W. 0., LI, P. P., GORDON, A. M. and STRAW, J., 1995, Pharmacokinetics of zidovudine in HIV-infected patients with end-stage renal disease. Blood Purification, 13, 340–346.
   Google Scholar
• KIRCH, W., RAMSCH, K. D., DUHRSEN, U. and OHNHAUS, E. E., 1984, Clinical pharmacokinetics of nimodipine in normal and impaired renal function. International Journal of Clinical Pharmacology Research, 4, 381–384.
   PubMedGoogle Scholar
• KLIN, M., SMOGORZEWSKI, M. and MASSRY, S. G., 1995, Chronic renal failure increases cytosolic Ca2± of hepatocytes. American Journal of Physiology, 269, G103–G109.
   Google Scholar
• KLIN, M., SMOGORZEWSKI, M., NI, Z., ZHANG, G. and MASSRY, S. G., 1996, Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. Journal of Clinical Investigation, 97, 2167–2173.
   PubMedGoogle Scholar
• KOOP, D. R., LAETHEM, R. M., GOLDNER, A. L. and DOUGLAS, J. G., 1991, Cytochrome P450 expression and metabolism in isolated rabbit renal epithelium. Methods in Enzymology, 206, 364–371.
   PubMedGoogle Scholar
• KRAUSE, R. J., LASH, L. H. and ELFARRA, A. A., 2003, Human kidney flavin-containing monooxygenases and their potential roles in cysteine s-conjugate metabolism and nephrotoxicity. Journal of Pharmacology Experimental Therapeutics, 304, 185–191.
   PubMed Web of Science ®Google Scholar
• KURDI, J., MAURICE, H., EL-KADI, A. 0., ONG, H., DALKARA, S., BELANGER, P. M. and SOUICH, P., 1999, Effect of hypoxia alone or combined with inflammation and 3-methylcholanthrene on hepatic cytochrome P450 in conscious rabbits. British Journal of Pharmacology, 128, 365–373.
   Google Scholar
• LAM, Y. W., BANERJI, S., HATFIELD, C. and TALBERT, R. L., 1997, Principles of drug administration in renal insufficiency. Clinical Pharmacokinetics, 32, 30–57.
   PubMed Web of Science ®Google Scholar
• LASH, L. H. and TOKARZ, J. J., 1989, Isolation of two distinct populations of cells from rat kidney cortex and their use in the study of chemical-induced toxicity. Analytical Biochemistry, 182, 271–279.
   PubMed Web of Science ®Google Scholar
• LEBLOND, F., GUEVIN, C., DEMERS, C., PELLERIN, I., GASCON-BARRE, M. and PICHETTE, V., 2001, Downregulation of hepatic cytochrome P450 in chronic renal failure. Journal of American Society of Nephrology, 12, 326–332.
   Google Scholar
• LEBLOND, F. A., GIROUX, L., VILLENEUVE, J. P. and PICHETTE, V., 2000, Decreased in vivo metabolism of drugs in chronic renal failure. Drug Metabolism and Disposition, 28, 1317–1320.
   PubMed Web of Science ®Google Scholar
• LEBLOND, F. A., PETRUCCI, M., DUBE, P., BERNIER, G., BONNARDEAUX, A. and PICHETTE, V., 2002, Downregulation of intestinal cytochrome p450 in chronic renal failure. Journal of American Society of Nephrology, 13, 1579–1585.
   PubMed Web of Science ®Google Scholar
• LEHMANN, C. R., HEIRONIMUS, J. D., COLLINS, C. B., O'NEIL., T. J., PIERSON, W. P., CROWE, J. T., MELIKIAN, A. P. and WRIGHT, G. J., 1985, Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis. Clinical Pharmacology and Therapeutics, 37, 284–289.
   Google Scholar
• LEMOINE, A., JOHANN, M. and CRESTEIL, T., 1990, Evidence for the presence of distinct flavin-containing monooxygenases in human tissues. Archives of Biochemistry and Biophysics, 276, 336–342.
   PubMedGoogle Scholar
• LLOYD, P., JOHN, V. A., SIG, M. and SMITH, S. E., 1990, The effect of impaired renal function on the pharmacokinetics of metoprolol after single administration of a 14/190 metoprolol OROS system. American Heart Journal, 120, 478–482.
   PubMedGoogle Scholar
• LOCK, E. A. and REED, C. J., 1998, Xenobiotic metabolizing enzymes of the kidney. Toxicological Pathology, 26, 18–25.
   PubMed Web of Science ®Google Scholar
• LOHR, J. W., WILLSKY, G. R. and ACARA, M. A., 1998, Renal drug-metabolism. Pharmacological Reviews, 50, 107–141.
   PubMed Web of Science ®Google Scholar
• LOWE, G. M., HULLEY, C. E., RHODES, E. S., YOUNG, A. J., BILTON, R. F., LOWE, G. M., HULLEY, C. E., RHODES, E. S., YOUNG, A. J. and BILTON, R. F., 1998, Free radical stimulation of tyrosine kinase and phosphatase activity in human peripheral blood mononuclear cells. Biochemical and Biophysical Research Communications, 245, 17–22.
   PubMed Web of Science ®Google Scholar
• MA, J., Qu, W., SCARBOROUGH, P. E., TOMER, K. B., MOOMAW, C. R., MARONPOT, R., DAVIS, L. S., BREYER, M. D. and ZELDIN, D. C., 1999, Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. Journal of Biological Chemistry, 274, 17777–17788.
   PubMed Web of Science ®Google Scholar
• MADDOCKS, J. L., WAKE, C. J. and HARBER, M. J., 1975, The plasma half-life of antipyrine in chronic uraemic and normal subjects. British Journal of Clinical Pharmacology, 2, 339–343.
   PubMed Web of Science ®Google Scholar
• MARATHE, G. V., NASH, B., HASCHEMEYER, R. H. and TATE, S. S., 1979, Ultrastructural localization of gamma glutamyl transpeptidase in rat kidney and jejunum. FEBS Letters, 107, 436–440.
   PubMed Web of Science ®Google Scholar
• MAYER, R. D., BERMAN, S., COCKETT, A. T. and MAINES, M. D., 1989, Differential effects of cyclosporin on hepatic and renal heme, cytochrome P-450 and drug-metabolism. Possible role in nephrotoxicity of the drug. Biochemical Pharmacology, 38, 1001–1017.
   PubMed Web of Science ®Google Scholar
• MuGuEE, K. A., BRIERLEY, C. H. and BURCHELL, B., 1998, Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochemical Pharmacology, 55, 1005–1012.
   PubMedGoogle Scholar
• McKAY, J. A., WEAVER, R. J., MURRAY, G. I., EWEN, S. W., MELVIN, W. T. and BURKE, M. D., 1995, Localization of microsomal epoxide hydrolase in normal and neoplastic human kidney. Journal of Histochemistry and Cytochemistry, 43, 615–620.
   PubMedGoogle Scholar
• MCLAREN, J., WHITING, P., SIMPSON, J. and HAWKSWORTH, G., 1995, Isolation and characterisation of human proximal tubular cells derived from kidney cortical segments. Human and Experimental Toxicology, 14, 916–922.
   PubMedGoogle Scholar
• MINAMIYAMA, Y., TAKEMURA, S., IMAOKA, S., FUNAE, Y., TANIMOTO, Y. and INouE, M., 1997, Irreversible inhibition of cytochrome P450 by nitric oxide. Journal of Pharmacology and Experimental Therapeutics, 283, 1479–1485.
   PubMed Web of Science ®Google Scholar
• MKRTCHIAN, S. L. and ANDERSSON, K. K., 1990, A possible role of cAMP dependent phosphorylation of hepatic microsomal cytochrome P450: a mechanism to increase lipid peroxidation in response to hormone. Biochemical and Biophysical Research Communications, 166, 787–793.
   PubMedGoogle Scholar
• MORGAN, E. T., 1997, Regulation of cytochromes P450 during inflammation and infection. Drug Metabolism Review, 29, 1129–1188.
   PubMed Web of Science ®Google Scholar
• MORGAN, E. T., 2001, Regulation of cytochrome p450 by inflammatory mediators: why and how? Drug Metabolism and Disposition, 29, 207–212.
   PubMed Web of Science ®Google Scholar
• MUNTANE-RELAT, J., OURLIN, J. C., DOMERGUE, J. and MAUREL, P., 1995, Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology, 22, 1143–1153.
   Google Scholar
• MURRAY, G. I., BARNES, T. S., SEWELL, H. F., EWEN, S. W., MELVIN, W. T. and BURKE, M. D., 1988, The immunocytochemical localization and distribution of cytochrome P-450 in normal hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450. British Journal of Pharmacology, 25, 465–475.
   Google Scholar
• MURRAY, G. I., MCFADYEN, M. C., MITCHELL, R. T., CHEUNG, Y. L., KERR, A. C. and MELVIN, W. T., 1999, Cytochrome P450 CYP3A in human renal cell cancer. British Journal of Cancer, 79, 1836–1842.
   PubMed Web of Science ®Google Scholar
• NAGASE, S., AOYAGI, K., GOTOH, M., HIRAYAMA, A., TOMIDA, C., SHIMOZAWA, Y. and KOYAM A., 1996, Increased lipid peroxidation by rat liver microsomes in experimental renal failure. Nephron, 74, 204–208.
   PubMedGoogle Scholar
• NEMETH, I. and SZELECZKI, T., 1981, Enhanced drug-metabolism and renal dysfunction. British Journal of Clinical Pharmacology, 11, 92–93.
   PubMedGoogle Scholar
• NORIS, M. and REMUZZI, G., 1999, Physiology and pathophysiology of nitric oxide in chronic renal disease. Proceedings of the Association of American Physicians, 111, 602–610.
   PubMedGoogle Scholar
• ODAR-CEDERLOF, I., ANDERSON, P. and BONDESSON, U., 1990, Nifedipine as an antihypertensive drug in patients with renal failure — pharmacokinetics and effects. Journal of Internal Medicine, 227, 329–337.
   PubMedGoogle Scholar
• OKAMOTO, T., MOMOSE, S. and HINO, 0., 2001, Suppression of cytochrome P450 1A1 and 4A1 gene expression in renal carcinomas of TSC2 gene mutant (Eker) rats. International Journal of Oncology, 18, 147–149.
   Google Scholar
• OMATA, K., ABE, K., SHEU, H. L., YOSHIDA, K., TSUTSUMI, E., YOSHINAGA, K., ABRAHAM, N. G. and LANIADO-SCHWARTZMAN, M., 1992, Roles of renal cytochrome P450-dependent arachidonic acid metabolites in hypertension. Tohoku Journal of Experimental Medicine, 166, 93–106.
   Google Scholar
• OVERBY, L. H., GARDLIK, S., PHILPOT, R. M. and SERABJIT-SINGH, C. J., 1994, Unique distribution profiles of glutathione 5-transferases in regions of kidney, ureter, and bladder of rabbit. Laboratory Investigation, 70, 468–478.
   Google Scholar
• PACIFICI, G. M., FRANCHI, M., BENCINI, C., REPETTI, F., DI LASCIO, N. and MURARO, G. B., 1988, Tissue distribution of drug-metabolizing enzymes in humans. Xenobiotica, 18, 849–856.
   PubMed Web of Science ®Google Scholar
• PASCUSSI, J. M., GERBAL-CHALOIN, S., PICHARD-GARCIA, L., DAUJAT, M., FABRE, J. M., MAUREL, P. and VILAREM, M. J., 2000, Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochemical and Biophysical Research Communications, 274, 707–713.
   Google Scholar
• PATTERSON, L. H., 2002, Bioreductively activated antitumor N-oxides: the case of AQ4N, a unique approach to hypoxia-activated cancer chemotherapy. Drug Metabolism Review, 34, 581-592. PATTERSON, L. H. and MURRAYM, G. I., 2002, Tumor cytochrome P450 and drug activation. Current Pharmaceutical Design, 8, 1335–1347.
   PubMed Web of Science ®Google Scholar
• PATTERSON, S. E. and COHN, V. H., 1984, Hepatic drug-metabolism in rats with experimental chronic renal failure. Biochemical Pharmacology, 33, 711–716.
   PubMed Web of Science ®Google Scholar
• PICKETT, C. B. and Lu, A. Y., 1989, Glutathione S-transferases: gene structure, regulation, and biological function. Annual Review of Biochemistry, 58, 743–764.
   PubMed Web of Science ®Google Scholar
• PRABHAKAR, S. S., 2002, L-arginine-nitric oxide pathway in end-stage renal disease. American Journal of Kidney Disease, 39, 195–198.
   PubMedGoogle Scholar
• PYERIN, W. and TANIGUCHI, H., 1989, Phosphorylation of hepatic phenobarbital-inducible cytochrome P-450. EMBO Journal, 8, 3003–3010.
   PubMed Web of Science ®Google Scholar
• QULALI, M., DUPLE, K. M. and CRABB, D. W 1993, Modulation of hepatic and renal alcohol dehydrogenase activity and mRNA by steroid hormones in vivo. Advances in Experimental Medicine and Biology, 328, 581–589.
   PubMedGoogle Scholar
• RAHMAN, M. and WRIGHT, J. T., JR and DOUGLAS, J. G., 1992, Roles of renal cytochrome P450-dependent arachidonic acid metabolites in hypertension. Tohoku Journal of Experimental Medicine, 166, 93–106.
   Google Scholar
• RINTALA, S., TAMMELA, T. L. and TUIMALA, R., 1998, CYP1A1 activity in renal cell carcinoma and in adjacent normal renal tissue. Urological Research, 26, 117–121.
   PubMed Web of Science ®Google Scholar
• RIVERS, B. J., WALTER, P. A., O'BRIEN, T. D., KING, V. L. and POLZIN, D. J., 1996, Evaluation of urine gamma-glutamyl transpeptidase-to-creatinine ratio as a diagnostic tool in an experimental model of aminoglycoside-induced acute renal failure in the dog. Journal American Animal Hospital Association, 32, 323–336.
   Google Scholar
• RODGERS, P. A. and STEVENSON, D. K., 1990, Developmental biology of heme oxygenase. Clinical Perinatology, 17, 275–291.
   PubMedGoogle Scholar
• RODILLA, V., BENZIE, A. A., VEITCH, J. M., MURRAY, G. I., ROWE, J. D. and HAWKSWORTH, G. M., 1998, Glutathione S-transferases in human renal cortex and neoplastic tissue, enzymatic activity, isoenzyme profile and immunohistochemical localization. Xenobiotica, 28, 443–456.
   PubMedGoogle Scholar
• RODRIGUEZ, M. J., SAURA, J., BILLETT, E. E., FINCH, C. C. and MAHY. N., 2001, Cellular localization of monoamine oxidase A and B in human tissues outside of the central nervous system. Cell and Tissue Research, 304, 215–220.
   Google Scholar
• SAKUMA, T., HONMA, R., MAGUCHI, S., TAMAKI, H. and NEMOTO, N., 2001, Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat. Xenobiotica, 31, 223–237.
   PubMed Web of Science ®Google Scholar
• SANDOCK, D. S., SEFTEL, A. D. and RESNICK, M. I., 1997, The role of gamma-glutamyl transpeptidase in the preoperative metastatic evaluation of renal cell carcinoma. Journal of Urology, 157, 798–799.
   PubMedGoogle Scholar
• SCARBOROUGH, P. E., MA, J., Qu, W. and ZELDIN, D. C., 1999, P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues. Drug Metabolism Review, 31, 205–234.
   PubMed Web of Science ®Google Scholar
• SCHAAF, G. J., DE GROENE, E. M., MAAS, R. F., COMMANDEUR, J. N. and FINK-GREMMELS, J., 2001, Characterization of biotransformation enzyme activities in primary rat proximal tubular cells. Chemico-biological interactions, 134, 167–190.
   Google Scholar
• SCHENKMAN, J. B, 1990, Induction of diabetes and evaluation of diabetic state on P450 expression. Methods in Enzymology, 206, 325–331.
   Google Scholar
• SCHUETZ, E. G., SCHUETZ, J. D., GROGAN, W. M., NARAY-FEJES-TOTH, A., FEJES-TOTH, G., RAUCY, J., GUZELIAN, P., GIONELA, K. and WATLINGTON, C. 0., 1999, Expression of cytochrome P450 3A in amphibian, rat, and human kidney. Archives of Biochemistry and Biophysics, 294, 206–214.
   Google Scholar
• SHIMOJO, N., ISHIZAKI, T., IMAOKA, S., FUNAE, Y., FUJII, S. and OKUDA, K., 1993, Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes. Biochemical Pharmacology, 46, 621–627.
   PubMed Web of Science ®Google Scholar
• SINGH, S. V., LEAD, T., ANSARI, G. A. S. and AWASTHI, Y. C., 1987, Purification and characterization of glutathione-S-transferase of human kidney. Biochemical Journal, 246, 179–186.
   Google Scholar
• SOCHOR, M., EL SHEIK, 0. K. and MCLEAN, P., 1980, y-Glutamyltransferase in glomeruli and tubules of rat kidney cortex: effect of experimental diabetes. Enzyme, 25, 205–208.
   Google Scholar
• SOTANIEMI, E. A., RAUTIO, A., BACKSTROM, M., ARVELA, P. and PELKONEN, 0., 1995, CYP3A4 and CYP2A6 activities marked by the metabolism of lignocaine and coumarin in patients with liver and kidney diseases and epileptic patients. British Journal of Clinical Pharmacology, 39, 71–76.
   Google Scholar
• STEVENS, J. L., 1985, Cysteine conjugate beta-lyase activities in rat kidney cortex: subcellular localization and relationship to the hepatic enzyme. Biochemical and Biophysical Research Communications, 129, 499–504.
   PubMed Web of Science ®Google Scholar
• STORSTEIN, L., LARSEN, A., MIDTBO, K. and SAEVAREID, L., 1984, Pharmacokinetics of calcium blockers in patients with renal insufficiency and in geriatric patients. Acta Medica Scandinavica Supplementum, 681, 25–30.
   PubMedGoogle Scholar
• SUNDSETH, S. S. and WAXMAN, D. J., 1992, Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. Journal of Biological Chemistry, 267, 3915–3921.
   PubMed Web of Science ®Google Scholar
• TANIGUCHI, H., PYERIN, W. and STIER, A., 1985, Conversion of hepatic microsomal cytochrome P-450 to P-420 upon phosphorylation by cyclic AMP dependent protein kinase. Biochemical Pharmacology, 34, 1835–1837.
   PubMed Web of Science ®Google Scholar
• TARLOFF, J. B., GOLDSTEIN, R. S., Sozio, R. S. and HOOK, J. B., 1991, Hepatic and renal conjugation (Phase II) enzyme activities in young adult, middle-aged, and senescent male Sprague-Dawley rats. Proceedings of the Society for Experimental Biology and Medicine, 197, 297–303.
   PubMedGoogle Scholar
• TERAO, N. and SHEN, D. D., 1984, Pharmacokinetics of 1-propranolol during repetitive dosing in normal and uranyl nitrate-induced renal failure rats. Journal of Pharmacokinetics and Biopharmaceutics, 12, 479–493.
   PubMedGoogle Scholar
• UCHIDA, N., KURATA, N., SHIMADA, K., NISHIMURA, Y., YASUDA, K., HASHIMOTO, M., UCHIDA, E. and YASUHARA, H., 1995, Changes of hepatic microsomal oxidative drug metabolizing enzymes in chronic renal failure (CRF) rats by partial nephrectomy. Japanese Journal of Pharmacology, 68, 431–439.
   PubMedGoogle Scholar
• VAN BOATEL, L., BOHM, R., MOOIJ, J., SCHIFFERS, P. and RAHN, K. H., 1989, Total and free steady-state plasma levels and pharmacokinetics of nifedipine in patients with terminal renal failure. European Journal of Clinical Pharmacology, 37, 185–189.
   PubMedGoogle Scholar
• VAN PEER, A. P., BELPAIRE, F. M. and BOGAERT, M. G., 1980, In vitro hepatic oxidative metabolism of antipyrine, phenytoin and phenylbutazone in uraemic rabbits. Journal of Pharmacy and Pharmacology, 32, 135–136.
   PubMedGoogle Scholar
• VAZIRI, N. D., Dicus, M., Ho, N. D., BOROUJERDI-RAD, L. and SINDHU, R. K., 2003, Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney International, 63, 179–185.
   Google Scholar
• VERBEECK, R. K., 1982, Glucuronidation and disposition of drug glucuronides in patients with renal failure. Drug Metabolism and Disposition, 10, 87–89.
   PubMedGoogle Scholar
• VERBEECK, R. K., BRANCH, R. A. and WILKINSON, G. R., 1981, Drug metabolites in renal failure: pharmacokinetic and clinical implications. Clinical Pharmacokinetics, 6, 329–345.
   PubMedGoogle Scholar
• VICKERS, A. E., FISCHER, V., CONNORS, M. S., BIGGI, W. A., HEITZ, F., BALDECK, J. P. and BRENDEL, K., 1996, Biotransformation of the antiemetic 5-HT3 antagonist tropisetron in liver and kidney slices of human, rat and dog with a comparison with in vivo. European Journal of Drug Metabolism and Pharmacokinetics, 21, 43–50.
   PubMed Web of Science ®Google Scholar
• VOGEL, W. H., GENTILE, N. T., MENDUKE, H. and BOEHME, D. H., 1983, Inter- and intraindividual differences in monoamine oxidase A and B activities in human central and peripheral tissues. Biochemical Medicine, 29, 392–397.
   PubMedGoogle Scholar
• WESTHUYZEN, J., ENDRE, Z. H., REECE, G., REITH, D. M., SALTISSI, D. and MORGAN, T. J., 2003, Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrology Dialysis Transplantation, 18, 543–551.
   PubMed Web of Science ®Google Scholar
• WIGGER, M., ARMSTRONG, V. W., SHIPKOVA, M., WACKE, R., NIZZE, H., STREIT, F., VON AHSEN, N., MUSCHEITES, J., GLASENAPP, S., STOLPE, H. J. and OELLERICH, M., 2002, Atypical pharmacokinetics and metabolism of mycophenolic acid in a young kidney transplant recipient with impaired renal function. Therapeutic Drug Monitoring, 24, 438–443.
   PubMed Web of Science ®Google Scholar
• YAMASHITA, K., FUJINAGA, T., HAGIO, M., MIYAMOTO, T., IzumisAwA, Y. and KOTANI, T., 1994, Bioassay for interleukin-1, interleukin-6, and tumor necrosis factor-like activities in canine sera. Journal of Veterinary Medical Sciences, 56, 103–107.
   PubMedGoogle Scholar
• YOSHIDA, T., KURELLA, M., BEATO, F., MIN, H., INGELFINGER, J. R., STEARS, R. L., SWINFORD, R. D., GULLANS, S. R. and TANG, S. S., 2002, Monitoring changes in gene expression in renal ischemia-reperfusion in the rat. Kidney International, 61, 1646–1654.
   PubMed Web of Science ®Google Scholar
• Yu, S. Y., CHUNG, H. C., KIM, E. J., KIM, S. H., LEE, I., KIM, S. G. and LEE, M. G., 2002, Effects of acute renal failure induced by uranyl nitrate on the pharmacokinetics of intravenous theophylline in rats: the role of CYP2E1 induction in 1,3-dimethyluric acid formation. Journal of Pharmacy and Pharmacology, 54, 1687–1692.
   PubMed Web of Science ®Google Scholar
• ZENSER, T. V. and DAVIS, B. B., 1984, Enzyme systems involved in the formation of reactive metabolites in the renal medulla: cooxidation via prostaglandin H synthase. Fundamentals of Applied Toxicology, 6, 922–929.
   Google Scholar
• ZENSER, T. V., RAPP, N. S., MATTAMMAL, M. B. and DAVIS, B. B., 1984, Renal cortical drug and xenobiotic metabolism following urinary tract obstruction. Kidney International, 25, 747–752.
   PubMedGoogle Scholar
• ZHAO, X., POLLOCK, D. M., INscHo, E. W., ZELDIN, D. C. and Imic, J. D., 2003, Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension. Hypertension, 41, 709–714.
   PubMed Web of Science ®Google Scholar